NEW YORK: The US Food and Drug Administration has approved Elon Musk’s company Neurolink to test the human brain after implanting a microchip in the human brain to help restore vision and mobility to people by linking brains to computers.
It says it does not have immediate plans to start recruiting participants. Mr Musk’s previous ambitions to begin tests came to nothing. Neurolink released a message on Twitter, saying, “We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!”.
We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!
This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our…
— Neuralink (@neuralink) May 25, 2023
Elon Musk said during a presentation on behalf of the startup in December that NeuralLink implants aim to enable human brains to communicate directly with computers.
“We are working hard to prepare our first human [implant],” he said at the time, “and obviously we want to be very careful before putting the device in a human that it will work well.”
Read more: Elon Musk says he has found new Twitter CEO
It should be noted that earlier in March 2023, the FDA refused to allow Neuralink to conduct such a clinical trial. The trial of this computer chip will start very soon but their request was rejected.
Now the FDA has given the go-ahead to begin clinical trials, and it comes after US lawmakers called for an investigative panel to scrutinize Neuralink’s animal experiments. is going.
